0|chunk|Synthetic long oligonucleotides to generate artificial templates for use as positive controls in molecular assays: drug resistance mutations in influenza virus as an example
0	15	31 oligonucleotides	Chemical	CHEBI_7754
0	115	119 drug	Chemical	CHEBI_23888
0	CHEBI-CHEBI	CHEBI_7754	CHEBI_23888

1|chunk|Background: Positive controls are an integral component of any sensitive molecular diagnostic tool, but this can be affected, if several mutations are being screened in a scenario of a pandemic or newly emerging disease where it can be difficult to acquire all the necessary positive controls from the host. This work describes the development of a synthetic oligo-cassette for positive controls for accurate and highly sensitive diagnosis of several mutations relevant to influenza virus drug resistance. Results: Using influenza antiviral drug resistance mutations as an example by employing the utility of synthetic paired long oligonucleotides containing complementary sequences at their 3' ends and utilizing the formation of oligonucleotide dimers and DNA polymerization, we generated~170bp dsDNA containing several known specific neuraminidase inhibitor (NAI) resistance mutations. These templates were further cloned and successfully applied as positive controls in downstream assays. Conclusion: This approach significantly improved the development of diagnosis of resistance mutations in terms of time, accuracy, efficiency and sensitivity, which are paramount to monitoring the emergence and spread of antiviral drug resistant influenza strains. Thus, this may have a significantly broader application in molecular diagnostics along with its application in rapid molecular testing of all relevant mutations in an event of pandemic.
1	489	493 drug	Chemical	CHEBI_23888
1	531	540 antiviral	Chemical	CHEBI_22587
1	531	545 antiviral drug	Chemical	CHEBI_36044
1	541	545 drug	Chemical	CHEBI_23888
1	631	647 oligonucleotides	Chemical	CHEBI_7754
1	731	746 oligonucleotide	Chemical	CHEBI_7754
1	758	761 DNA	Chemical	CHEBI_16991
1	837	860 neuraminidase inhibitor	Chemical	CHEBI_52425
1	851	860 inhibitor	Chemical	CHEBI_35222
1	862	865 NAI	Chemical	CHEBI_33167
1	1213	1222 antiviral	Chemical	CHEBI_22587
1	1213	1227 antiviral drug	Chemical	CHEBI_36044
1	1223	1227 drug	Chemical	CHEBI_23888
1	CHEBI-CHEBI	CHEBI_23888	CHEBI_22587
1	CHEBI-CHEBI	CHEBI_23888	CHEBI_36044
1	CHEBI-CHEBI	CHEBI_23888	CHEBI_7754
1	CHEBI-CHEBI	CHEBI_23888	CHEBI_16991
1	CHEBI-CHEBI	CHEBI_23888	CHEBI_52425
1	CHEBI-CHEBI	CHEBI_23888	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_23888	CHEBI_33167
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_36044
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_7754
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_16991
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_52425
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_33167
1	CHEBI-CHEBI	CHEBI_36044	CHEBI_7754
1	CHEBI-CHEBI	CHEBI_36044	CHEBI_16991
1	CHEBI-CHEBI	CHEBI_36044	CHEBI_52425
1	CHEBI-CHEBI	CHEBI_36044	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_36044	CHEBI_33167
1	CHEBI-CHEBI	CHEBI_7754	CHEBI_16991
1	CHEBI-CHEBI	CHEBI_7754	CHEBI_52425
1	CHEBI-CHEBI	CHEBI_7754	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_7754	CHEBI_33167
1	CHEBI-CHEBI	CHEBI_16991	CHEBI_52425
1	CHEBI-CHEBI	CHEBI_16991	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_16991	CHEBI_33167
1	CHEBI-CHEBI	CHEBI_52425	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_52425	CHEBI_33167
1	CHEBI-CHEBI	CHEBI_35222	CHEBI_33167

